CHICAGO TRUST Co NA Purchases 665 Shares of Intuitive Surgical, Inc. $ISRG

Key Points

• CHICAGO TRUST Co NA increased its holdings in Intuitive Surgical, Inc. by 49.5% during the second quarter, now owning a total of 2,009 shares valued at $1,092,000.
• Multiple institutional investors, including Vanguard Group and Wellington Management Group, have also increased their stakes, highlighting strong confidence in the company with 83.64% of the stock currently held by institutional investors.
• Intuitive Surgical recently reported earnings of $2.19 EPS, surpassing estimates, with revenues of $2.44 billion for the quarter, reflecting a 21.4% year-over-year revenue increase.

CHICAGO TRUST Co NA increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 49.5% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,009 shares of the medical equipment provider's stock after purchasing an additional 665 shares during the period. CHICAGO TRUST Co NA's holdings in Intuitive Surgical were worth $1,092,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. raised its holdings in Intuitive Surgical by 1.4% during the 1st quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider's stock valued at $16,178,258,000 after buying an additional 453,335 shares during the period. Invesco Ltd. boosted its stake in shares of Intuitive Surgical by 1.7% during the 1st quarter. Invesco Ltd. now owns 4,219,974 shares of the medical equipment provider's stock worth $2,090,027,000 after purchasing an additional 71,794 shares during the period. Northern Trust Corp boosted its stake in shares of Intuitive Surgical by 0.3% during the 1st quarter. Northern Trust Corp now owns 3,631,281 shares of the medical equipment provider's stock worth $1,798,465,000 after purchasing an additional 11,988 shares during the period. Wellington Management Group LLP boosted its stake in shares of Intuitive Surgical by 15.0% during the 1st quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider's stock worth $1,732,975,000 after purchasing an additional 457,080 shares during the period. Finally, Nuveen LLC purchased a new stake in Intuitive Surgical in the 1st quarter valued at about $1,715,899,000. 83.64% of the stock is currently owned by institutional investors.

Insider Activity

In other news, EVP Myriam Curet sold 4,500 shares of the stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the sale, the executive vice president directly owned 353 shares in the company, valued at $173,845.44. This represents a 92.73% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Gary S. Guthart sold 29,360 shares of the stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the sale, the insider owned 19,827 shares of the company's stock, valued at $9,368,059.23. This trade represents a 59.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 45,224 shares of company stock worth $21,716,492 over the last three months. Insiders own 0.70% of the company's stock.

Analyst Ratings Changes

ISRG has been the subject of several research reports. Truist Financial boosted their price objective on shares of Intuitive Surgical from $590.00 to $600.00 and gave the company a "buy" rating in a research report on Wednesday, July 23rd. Piper Sandler reissued an "overweight" rating and issued a $595.00 price objective (up from $575.00) on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Zacks Research cut shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, August 20th. Wells Fargo & Company boosted their price objective on shares of Intuitive Surgical from $559.00 to $599.00 and gave the company an "overweight" rating in a research report on Wednesday, July 23rd. Finally, Erste Group Bank restated a "hold" rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Thirteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $595.95.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $444.55 on Tuesday. The company has a fifty day moving average of $475.20 and a two-hundred day moving average of $502.92. The stock has a market capitalization of $159.36 billion, a PE ratio of 62.00, a P/E/G ratio of 4.60 and a beta of 1.61. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating analysts' consensus estimates of $1.93 by $0.26. The business had revenue of $2.44 billion during the quarter, compared to analysts' expectations of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The company's quarterly revenue was up 21.4% compared to the same quarter last year. During the same period in the prior year, the business earned $1.78 earnings per share. Research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.